東嶽硅材(300821.SZ):參股公司未來材料申請首次公開發行股票並在上海證券交易所上市輔導驗收完成
格隆匯6月17日丨東嶽硅材(300821.SZ)公佈,參股公司未來材料擬向社會公眾首次公開發行人民幣普通股(A股)股票並在上海證券交易所科創板上市,公司作為未來材料股東,直接持有其2,275萬股股份,佔本次公開發行股票前未來材料總股本的5.14%。近日,公司收到未來材料書面吿知,根據《證券發行上市保薦業務管理辦法》《首次公開發行股票並上市輔導監管規定》等規定,山東證監局完成對未來材料申請首次公開發行股票並在上海證券交易所科創板上市輔導工作的驗收。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.